Shannon Lauberth

1.6k total citations
17 papers, 1.1k citations indexed

About

Shannon Lauberth is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Shannon Lauberth has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Immunology. Recurrent topics in Shannon Lauberth's work include RNA modifications and cancer (7 papers), Epigenetics and DNA Methylation (5 papers) and RNA Research and Splicing (5 papers). Shannon Lauberth is often cited by papers focused on RNA modifications and cancer (7 papers), Epigenetics and DNA Methylation (5 papers) and RNA Research and Splicing (5 papers). Shannon Lauberth collaborates with scholars based in United States, Germany and Philippines. Shannon Lauberth's co-authors include Vittorio Sartorelli, Michael Rauchman, Stephen H. Hughes, Andrea L. Ferris, Takahiro Nakayama, Xiaolin Wu, R G Roeder, Zhanyun Tang, Homa Rahnamoun and Hanbin Lu and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Shannon Lauberth

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shannon Lauberth United States	11	892	231	108	105	94	17	1.1k
Senthilkumar Cinghu United States	12	706 0.8×	156 0.7×	52 0.5×	136 1.3×	54 0.6×	16	842
Kendra Allton United States	11	909 1.0×	305 1.3×	153 1.4×	254 2.4×	77 0.8×	15	1.1k
Dilafruz Juraeva Germany	12	351 0.4×	213 0.9×	131 1.2×	143 1.4×	55 0.6×	24	687
Robert Liefke Germany	15	949 1.1×	119 0.5×	57 0.5×	69 0.7×	124 1.3×	29	1.1k
Chiara Vardabasso United States	9	740 0.8×	120 0.5×	83 0.8×	159 1.5×	51 0.5×	12	873
Nicki Gray United Kingdom	11	533 0.6×	123 0.5×	74 0.7×	46 0.4×	66 0.7×	12	704
Amanda E. Jones United States	14	828 0.9×	111 0.5×	71 0.7×	109 1.0×	107 1.1×	18	922
Honghong Zhou China	16	573 0.6×	181 0.8×	68 0.6×	158 1.5×	97 1.0×	27	715
Richard C. Centore United States	12	1.0k 1.2×	120 0.5×	47 0.4×	164 1.6×	200 2.1×	17	1.1k
Tomoyoshi Nakadai Japan	16	778 0.9×	112 0.5×	52 0.5×	85 0.8×	101 1.1×	36	939

Countries citing papers authored by Shannon Lauberth

Since Specialization

Citations

This map shows the geographic impact of Shannon Lauberth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon Lauberth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon Lauberth more than expected).

Fields of papers citing papers by Shannon Lauberth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shannon Lauberth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon Lauberth. The network helps show where Shannon Lauberth may publish in the future.

Co-authorship network of co-authors of Shannon Lauberth

This figure shows the co-authorship network connecting the top 25 collaborators of Shannon Lauberth. A scholar is included among the top collaborators of Shannon Lauberth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shannon Lauberth. Shannon Lauberth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Schauer, Tamás, Jianfeng Sun, Jonas J. Funke, et al.. (2025). H4K16 acylations destabilize chromatin architecture and facilitate transcriptional response during metabolic perturbations. Molecular Cell. 86(1). 24–40.e10.

Rahnamoun, Homa, Bei Liu, Prachi Patel, et al.. (2024). RNA interacts with topoisomerase I to adjust DNA topology. Molecular Cell. 84(17). 3192–3208.e11. 5 indexed citations

Yang, Guang‐Yu, et al.. (2024). Downstream-of-gene (DoG) transcripts contribute to an imbalance in the cancer cell transcriptome. Science Advances. 10(27). eadh9613–eadh9613. 6 indexed citations

Bui, Triet M., Xingsheng Ren, Brian Wray, et al.. (2024). Tissue-specific reprogramming leads to angiogenic neutrophil specialization and tumor vascularization in colorectal cancer. Journal of Clinical Investigation. 134(7). 28 indexed citations

Lauberth, Shannon, et al.. (2023). Exploring new roles for RNA-binding proteins in epigenetic and gene regulation. Current Opinion in Genetics & Development. 84. 102136–102136. 6 indexed citations

Wester, James R., et al.. (2022). Clinical and Histopathologic Characterization of SETD2-Mutated Colorectal Cancer. SSRN Electronic Journal. 1 indexed citations

Morgan, Marc A., Ramin Shiekhattar, Ali Shilatifard, & Shannon Lauberth. (2022). It’s a DoG-eat-DoG world—altered transcriptional mechanisms drive downstream-of-gene (DoG) transcript production. Molecular Cell. 82(11). 1981–1991. 13 indexed citations

Wester, James R., Samuel E. Weinberg, Juehua Gao, et al.. (2022). Clinical and histopathologic characterization of SETD2-mutated colorectal cancer. Human Pathology. 131. 9–16. 8 indexed citations

Sartorelli, Vittorio & Shannon Lauberth. (2020). Enhancer RNAs are an important regulatory layer of the epigenome. Nature Structural & Molecular Biology. 27(6). 521–528. 230 indexed citations

10.

Rahnamoun, Homa, et al.. (2019). The role of enhancer RNAs in epigenetic regulation of gene expression. Transcription. 11(1). 19–25. 12 indexed citations

11.

Rahnamoun, Homa, Ji Hoon Lee, Zhengxi Sun, et al.. (2018). RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation. Nature Structural & Molecular Biology. 25(8). 687–697. 126 indexed citations

12.

Rahnamoun, Homa, Juyeong Hong, Zhengxi Sun, et al.. (2018). Mutant p53 regulates enhancer-associated H3K4 monomethylation through interactions with the methyltransferase MLL4. Journal of Biological Chemistry. 293(34). 13234–13246. 28 indexed citations

13.

Rahnamoun, Homa, Hanbin Lu, Sascha H. Duttke, et al.. (2017). Mutant p53 shapes the enhancer landscape of cancer cells in response to chronic immune signaling. Nature Communications. 8(1). 754–754. 77 indexed citations

14.

Giardoglou, Tota, David R. Jones, Kathy A. Gelato, et al.. (2015). The Basal Transcription Complex Component TAF3 Transduces Changes in Nuclear Phosphoinositides into Transcriptional Output. Molecular Cell. 58(3). 453–467. 55 indexed citations

15.

Lauberth, Shannon, Takahiro Nakayama, Xiaolin Wu, et al.. (2013). H3K4me3 Interactions with TAF3 Regulate Preinitiation Complex Assembly and Selective Gene Activation. Cell. 152(5). 1021–1036. 328 indexed citations

16.

Lauberth, Shannon, et al.. (2007). A Phosphomimetic Mutation in the Sall1 Repression Motif Disrupts Recruitment of the Nucleosome Remodeling and Deacetylase Complex and Repression of Gbx2. Journal of Biological Chemistry. 282(48). 34858–34868. 35 indexed citations

17.

Lauberth, Shannon & Michael Rauchman. (2006). A Conserved 12-Amino Acid Motif in Sall1 Recruits the Nucleosome Remodeling and Deacetylase Corepressor Complex. Journal of Biological Chemistry. 281(33). 23922–23931. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact